Pub Date : 2025-11-19DOI: 10.1016/j.diii.2025.11.004
Toulsie Ramtohul
{"title":"Breast MR imaging without gadolinium-based contrast agents: A visionary goal or scientific mirage?","authors":"Toulsie Ramtohul","doi":"10.1016/j.diii.2025.11.004","DOIUrl":"10.1016/j.diii.2025.11.004","url":null,"abstract":"","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":"107 2","pages":"Pages 49-50"},"PeriodicalIF":8.1,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-15DOI: 10.1016/j.diii.2025.11.002
Farah Cadour, Jean-Nicolas Dacher
{"title":"Photon-counting CT myocardial perfusion imaging: A future candidate in the guidelines for functional assessment of coronary artery disease.","authors":"Farah Cadour, Jean-Nicolas Dacher","doi":"10.1016/j.diii.2025.11.002","DOIUrl":"https://doi.org/10.1016/j.diii.2025.11.002","url":null,"abstract":"","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-08DOI: 10.1016/j.diii.2025.10.009
Chiara Pozzessere , Paul Habert , Mathieu Lederlin
{"title":"From voxel to treatment response: Rethinking the role of imaging in cystic fibrosis in the era of artificial intelligence","authors":"Chiara Pozzessere , Paul Habert , Mathieu Lederlin","doi":"10.1016/j.diii.2025.10.009","DOIUrl":"10.1016/j.diii.2025.10.009","url":null,"abstract":"","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":"107 2","pages":"Pages 47-48"},"PeriodicalIF":8.1,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dynamic contrast-enhanced magnetic resonance imaging remains a cornerstone of breast cancer diagnosis, yet concerns regarding the safety, environmental impact, and cost of gadolinium-based contrast agents are driving the development of gadolinium-based contrast agent-free alternatives. This review outlines emerging non-contrast imaging modalities that support a more sustainable approach to breast cancer diagnosis. Advanced MRI techniques, such as diffusion-weighted imaging and synthetic MRI, provide detailed tissue characterization without the need for contrast agents. In computed tomography (CT), innovations including dual-energy CT and photon-counting detector CT are improving lesion detection and characterization, with photon-counting detector CT offering exceptional spatial resolution. Molecular imaging with positron emission tomography is also advancing beyond 18F-fluorodeoxyglucose, incorporating dedicated high-resolution systems and novel tracers targeting specific biomarkers, such as 16α-18F-fluoro-17β-estradiol for estrogen receptors, fibroblast activation protein inhibitors, and human epidermal growth factor receptor 2–targeted agents. The future of breast imaging is likely to adopt a multimodal strategy, combining these innovations to deliver more accurate, personalized, and sustainable patient care.
{"title":"Breast cancer imaging without gadolinium-based contrast agent: A review of current applications and future trends","authors":"Maya Honda , Mami Iima , Masako Kataoka , Daiju Ueda , Tsukasa Saida , Kentaro Nishioka , Ryo Kurokawa , Satoru Ide , Masahiro Yanagawa , Tadashi Watabe , Kenji Hirata , Rintaro Ito , Seitaro Oda , Koji Takumi , Mariko Kawamura , Shunsuke Sugawara , Keitaro Sofue , Akihiko Sakata , Shinji Naganawa","doi":"10.1016/j.diii.2025.10.004","DOIUrl":"10.1016/j.diii.2025.10.004","url":null,"abstract":"<div><div>Dynamic contrast-enhanced magnetic resonance imaging remains a cornerstone of breast cancer diagnosis, yet concerns regarding the safety, environmental impact, and cost of gadolinium-based contrast agents are driving the development of gadolinium-based contrast agent-free alternatives. This review outlines emerging non-contrast imaging modalities that support a more sustainable approach to breast cancer diagnosis. Advanced MRI techniques, such as diffusion-weighted imaging and synthetic MRI, provide detailed tissue characterization without the need for contrast agents. In computed tomography (CT), innovations including dual-energy CT and photon-counting detector CT are improving lesion detection and characterization, with photon-counting detector CT offering exceptional spatial resolution. Molecular imaging with positron emission tomography is also advancing beyond <sup>18</sup>F-fluorodeoxyglucose, incorporating dedicated high-resolution systems and novel tracers targeting specific biomarkers, such as 16α-<sup>18</sup>F-fluoro-17β-estradiol for estrogen receptors, fibroblast activation protein inhibitors, and human epidermal growth factor receptor 2–targeted agents. The future of breast imaging is likely to adopt a multimodal strategy, combining these innovations to deliver more accurate, personalized, and sustainable patient care.</div></div>","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":"107 2","pages":"Pages 51-61"},"PeriodicalIF":8.1,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-04DOI: 10.1016/j.diii.2025.10.006
Marie-Pauline Talabard , Marie Faruch-Bilfeld
{"title":"Mineralized-tissue MRI: A new standard for sacroiliac joint imaging","authors":"Marie-Pauline Talabard , Marie Faruch-Bilfeld","doi":"10.1016/j.diii.2025.10.006","DOIUrl":"10.1016/j.diii.2025.10.006","url":null,"abstract":"","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":"107 2","pages":"Pages 45-46"},"PeriodicalIF":8.1,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-30DOI: 10.1016/j.diii.2025.10.005
Benjamin Longère, Hippolyte Caseneuve, Christos V Gkizas, Aimée Rodriguez Musso, Mariia Tregubova, Cédric Croisille, Mehdi Haidar, François Pontana
Purpose: The purpose of this study was to evaluate the feasibility and diagnostic performance of stress myocardial perfusion imaging (MPI) using a first-generation dual-source photon-counting CT (PCCT) scanner by comparison with reference standards.
Materials and methods: Consecutive patients referred for coronary CT angiography (CCTA) with concomitant stress MPI using PCCT scanner and at least one functional reference test within one month were included. Static PCCT-MPI with regadenoson (Rapiscan, GE Healthcare) was acquired 12 s after the intravenous administration of 40 mL of iodinated contrast material and paired with myocardial delayed enhancement imaging. Reference tests for ischemia included stress cardiac magnetic resonance imaging, stress echocardiography, single-photon emission computed tomography, or invasive coronary angiography. Diagnostic performance was evaluated using sensitivity, specificity, accuracy, areas under receiver operating characteristic curve analysis (AUC) as well as Youden index-derived thresholds.
Results: Forty-one patients were included. There were 28 men and 13 women with a median age of 62 years (Q1, 57; Q3, 70; range: 18-85 years). Of these, 35 patients (85 %) had obstructive coronary artery disease (CAD) on CCTA. PCCT-MPI identified myocardial hypoperfusion in 18 patients (44 %) with a median dose-length product of 97 mGy.cm (Q1, 76.8; Q3, 155.8). Visual assessment yielded 100 % sensitivity (95 % confidence interval [CI]: 81-100 %) and 96 % specificity (95 % CI: 78-100 %), with an AUC of 0.98 (95 % CI: 0.93-1.00) for the diagnosis of ischemic and infarcted myocardium. An optimal defect-to-remote iodine ratio cutoff of 0.79 showed 98 % accuracy (95 % CI: 87-100 %) and an AUC of 0.99 (95 % CI: 0.98-1.00 %). Integration of PCCT-MPI with CCTA could have obviated additional functional testing or invasive angiography in up to 50 % of patients with obstructive CAD.
Conclusion: Stress static PCCT-MPI is feasible and demonstrates excellent diagnostic accuracy for detecting myocardial ischemia. Defect-to-remote iodine ratio from spectral imaging further enhances performance, establishing PCCT as a comprehensive imaging modality that unifies anatomic and functional coronary assessment at a reasonable radiation dose, within a single examination.
{"title":"Stress myocardial perfusion imaging with photon-counting CT: Initial validation against reference modalities.","authors":"Benjamin Longère, Hippolyte Caseneuve, Christos V Gkizas, Aimée Rodriguez Musso, Mariia Tregubova, Cédric Croisille, Mehdi Haidar, François Pontana","doi":"10.1016/j.diii.2025.10.005","DOIUrl":"https://doi.org/10.1016/j.diii.2025.10.005","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to evaluate the feasibility and diagnostic performance of stress myocardial perfusion imaging (MPI) using a first-generation dual-source photon-counting CT (PCCT) scanner by comparison with reference standards.</p><p><strong>Materials and methods: </strong>Consecutive patients referred for coronary CT angiography (CCTA) with concomitant stress MPI using PCCT scanner and at least one functional reference test within one month were included. Static PCCT-MPI with regadenoson (Rapiscan, GE Healthcare) was acquired 12 s after the intravenous administration of 40 mL of iodinated contrast material and paired with myocardial delayed enhancement imaging. Reference tests for ischemia included stress cardiac magnetic resonance imaging, stress echocardiography, single-photon emission computed tomography, or invasive coronary angiography. Diagnostic performance was evaluated using sensitivity, specificity, accuracy, areas under receiver operating characteristic curve analysis (AUC) as well as Youden index-derived thresholds.</p><p><strong>Results: </strong>Forty-one patients were included. There were 28 men and 13 women with a median age of 62 years (Q1, 57; Q3, 70; range: 18-85 years). Of these, 35 patients (85 %) had obstructive coronary artery disease (CAD) on CCTA. PCCT-MPI identified myocardial hypoperfusion in 18 patients (44 %) with a median dose-length product of 97 mGy.cm (Q1, 76.8; Q3, 155.8). Visual assessment yielded 100 % sensitivity (95 % confidence interval [CI]: 81-100 %) and 96 % specificity (95 % CI: 78-100 %), with an AUC of 0.98 (95 % CI: 0.93-1.00) for the diagnosis of ischemic and infarcted myocardium. An optimal defect-to-remote iodine ratio cutoff of 0.79 showed 98 % accuracy (95 % CI: 87-100 %) and an AUC of 0.99 (95 % CI: 0.98-1.00 %). Integration of PCCT-MPI with CCTA could have obviated additional functional testing or invasive angiography in up to 50 % of patients with obstructive CAD.</p><p><strong>Conclusion: </strong>Stress static PCCT-MPI is feasible and demonstrates excellent diagnostic accuracy for detecting myocardial ischemia. Defect-to-remote iodine ratio from spectral imaging further enhances performance, establishing PCCT as a comprehensive imaging modality that unifies anatomic and functional coronary assessment at a reasonable radiation dose, within a single examination.</p>","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-30DOI: 10.1016/j.diii.2025.10.007
Rémi Grange, Nazim Benzerdjeb, Salim Si-Mohamed, Marie Gavrel, Alexandre Galan, Laurent Villeneuve, Olivier Glehen, Vahan Kepenekian, Pascal Rousset
Purpose: The purpose of this prospective study was to evaluate the diagnostic performance of dual-energy computed tomography (DECT) using a dual-layer detector scanner in assessing the pathological response of peritoneal metastases (PMs) from non-mucinous colorectal cancer to neoadjuvant chemotherapy (NAC).
Materials and methods: Consecutive patients with PMs from non-mucinous colorectal cancer who underwent preoperative DECT using a dual-layer detector scanner before cytoreductive surgery were prospectively included. Virtual monoenergetic images at 40 keV (VMI40kev), VMIs at 100 keV (VMI100kev), VMI slope (VMIslope), iodine concentration (IC), normalized iodine concentration with aorta (nICaorta) and liver (nICliver), effective Z atomic number (Zeff), and extracellular volume fraction (ECVf) were evaluated on PMs by two radiologists. Pathological response of PM was classified using the peritoneal regression grading score (PRGS), and classified as either good (complete response or major histological regression - PRGS ½) or poor (minor or no histological response - PRGS ¾) responses. DECT variables of PMs with good responses were compared to those of PMs with poor responses using independent-sample t-tests. Receiver operating characteristic curves were built to estimate the capabilities of the different DECT variables in differentiating between PMs with good responses (PRGS ½) and those with poor responses (PRGS ¾). Intra-class correlation coefficients analyses were performed to estimate interobserver variability in DECT variable measurements.
Results: Forty-four patients (22 men median age, 62 years; age range: 35-78 years) with 77 PM were included from September 1st 2023 to July 1st 2025. Thirty-nine out of 77 PMs (51 %) exhibited good response (PRGS ½) and 38 PMs (49 %) exhibited poor response (PRGS ¾). VMI40kev, VMIslope, IC, nICaorta, nICliver, ECVf were significantly greater in PRGS ¾ PMs by comparison with PRGS ½ (P < 0.05). The best AUC values to distinguish between good and poor pathological response of PMs were obtained with nICaorta (AUC, 0.74: 95 % confidence interval [CI]: 0.63-0.85) and ECVf (AUC, 0.74; 95 % CI: 0.63-0.84). ICC was > 0.8 for most DECT variables.
Conclusion: DECT using a dual-layer detector scanner provides promising biomarkers for predicting pathological response in non-mucinous PM after chemotherapy.
{"title":"Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT.","authors":"Rémi Grange, Nazim Benzerdjeb, Salim Si-Mohamed, Marie Gavrel, Alexandre Galan, Laurent Villeneuve, Olivier Glehen, Vahan Kepenekian, Pascal Rousset","doi":"10.1016/j.diii.2025.10.007","DOIUrl":"https://doi.org/10.1016/j.diii.2025.10.007","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this prospective study was to evaluate the diagnostic performance of dual-energy computed tomography (DECT) using a dual-layer detector scanner in assessing the pathological response of peritoneal metastases (PMs) from non-mucinous colorectal cancer to neoadjuvant chemotherapy (NAC).</p><p><strong>Materials and methods: </strong>Consecutive patients with PMs from non-mucinous colorectal cancer who underwent preoperative DECT using a dual-layer detector scanner before cytoreductive surgery were prospectively included. Virtual monoenergetic images at 40 keV (VMI<sub>40kev</sub>), VMIs at 100 keV (VMI<sub>100kev</sub>), VMI slope (VMI<sub>slope</sub>), iodine concentration (IC), normalized iodine concentration with aorta (nIC<sub>aorta</sub>) and liver (nIC<sub>liver</sub>), effective Z atomic number (Z<sub>eff</sub>), and extracellular volume fraction (ECVf) were evaluated on PMs by two radiologists. Pathological response of PM was classified using the peritoneal regression grading score (PRGS), and classified as either good (complete response or major histological regression - PRGS ½) or poor (minor or no histological response - PRGS ¾) responses. DECT variables of PMs with good responses were compared to those of PMs with poor responses using independent-sample t-tests. Receiver operating characteristic curves were built to estimate the capabilities of the different DECT variables in differentiating between PMs with good responses (PRGS ½) and those with poor responses (PRGS ¾). Intra-class correlation coefficients analyses were performed to estimate interobserver variability in DECT variable measurements.</p><p><strong>Results: </strong>Forty-four patients (22 men median age, 62 years; age range: 35-78 years) with 77 PM were included from September 1st 2023 to July 1st 2025. Thirty-nine out of 77 PMs (51 %) exhibited good response (PRGS ½) and 38 PMs (49 %) exhibited poor response (PRGS ¾). VMI<sub>40kev</sub>, VMI<sub>slope</sub>, IC, nIC<sub>aorta</sub>, nIC<sub>liver</sub>, ECVf were significantly greater in PRGS ¾ PMs by comparison with PRGS ½ (P < 0.05). The best AUC values to distinguish between good and poor pathological response of PMs were obtained with nIC<sub>aorta</sub> (AUC, 0.74: 95 % confidence interval [CI]: 0.63-0.85) and ECVf (AUC, 0.74; 95 % CI: 0.63-0.84). ICC was > 0.8 for most DECT variables.</p><p><strong>Conclusion: </strong>DECT using a dual-layer detector scanner provides promising biomarkers for predicting pathological response in non-mucinous PM after chemotherapy.</p>","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":" ","pages":""},"PeriodicalIF":8.1,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.diii.2025.05.007
Nicolas Douis , Elodie Marchand , Gwendoline Wary , Romain Gillet , Martin Kolopp , Alain Blum , Laurent Martrille
Three-dimensional (3D) post-processing is now an essential part of postmortem forensic computed tomography (CT) imaging. Recent advances in this field include the development of sophisticated reconstruction algorithms, such as global illumination rendering. These tools enable the photorealistic, synthetic, and selective visualization of complex anatomical information with high degrees of accuracy. This technology is particularly valuable in bone injury cases because it facilitates lesion mechanism analysis. 3D representations are valuable tools in forensic investigations, including radiological analysis, communicating results, preparing autopsies, and presenting forensic findings in court. Several factors influence the quality of the final 3D representation, including the technical parameters of CT data acquisition and the appropriate use of post-processing software. This review provides an overview of the key factors that determine the quality of 3D forensic CT images, examines their applications and limitations, and discusses future directions.
{"title":"3D post-processing in postmortem forensic imaging: Techniques, applications, and future directions","authors":"Nicolas Douis , Elodie Marchand , Gwendoline Wary , Romain Gillet , Martin Kolopp , Alain Blum , Laurent Martrille","doi":"10.1016/j.diii.2025.05.007","DOIUrl":"10.1016/j.diii.2025.05.007","url":null,"abstract":"<div><div>Three-dimensional (3D) post-processing is now an essential part of postmortem forensic computed tomography (CT) imaging. Recent advances in this field include the development of sophisticated reconstruction algorithms, such as global illumination rendering. These tools enable the photorealistic, synthetic, and selective visualization of complex anatomical information with high degrees of accuracy. This technology is particularly valuable in bone injury cases because it facilitates lesion mechanism analysis. 3D representations are valuable tools in forensic investigations, including radiological analysis, communicating results, preparing autopsies, and presenting forensic findings in court. Several factors influence the quality of the final 3D representation, including the technical parameters of CT data acquisition and the appropriate use of post-processing software. This review provides an overview of the key factors that determine the quality of 3D forensic CT images, examines their applications and limitations, and discusses future directions.</div></div>","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":"106 10","pages":"Pages 337-344"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.diii.2025.05.002
Julien Ognard , Marie Schmidt , Christophe Paya , Isabelle Le Du , Camille Bourillon , Mourad Cheddad El Aouni , Ludwig Serge Aho Glele , Riitta Rautio , Sara Lojo-Lendoiro , Omer F. Eker , Vanessa Brun , Xianli Lv , Erwan L’Her , Raphaël Tripier , Abdelghani Fakhreddine Boustia , Betty Jean , Jean-Christophe Gentric , Cyril Leven , Douraied Ben Salem
{"title":"The continued industrial use of ethylene oxide despite health risks: An interventional radiology perspective on a broader medical challenge of balancing sterility, safety, and sustainability","authors":"Julien Ognard , Marie Schmidt , Christophe Paya , Isabelle Le Du , Camille Bourillon , Mourad Cheddad El Aouni , Ludwig Serge Aho Glele , Riitta Rautio , Sara Lojo-Lendoiro , Omer F. Eker , Vanessa Brun , Xianli Lv , Erwan L’Her , Raphaël Tripier , Abdelghani Fakhreddine Boustia , Betty Jean , Jean-Christophe Gentric , Cyril Leven , Douraied Ben Salem","doi":"10.1016/j.diii.2025.05.002","DOIUrl":"10.1016/j.diii.2025.05.002","url":null,"abstract":"","PeriodicalId":48656,"journal":{"name":"Diagnostic and Interventional Imaging","volume":"106 10","pages":"Pages 353-355"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号